DENTSPLY SIRONA Inc. (XRAY) is a Medical - Instruments & Supplies company in the Healthcare sector, currently trading at $12.22. It has a SharesGrow Score of 32/100, indicating a weak investment profile with 1 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of XRAY = $14.39 (+17.8% from the current price, the stock appears undervalued). Analyst consensus target is XRAY = $13 (+9.1% upside).
Valuation: XRAY trades at a trailing Price-to-Earnings (P/E) of -3.9 (S&P 500 average ~25).
Financials: revenue is $3.7B, -2.1%/yr average growth. Net income is $598M (loss), growing at -156.3%/yr. Net profit margin is -16.3% (negative). Gross margin is 50% (-4.2 pp trend).
Balance sheet: total debt is $2.5B against $1.3B equity (Debt-to-Equity (D/E) ratio 1.84, leveraged). Current ratio is 1.51 (strong liquidity). Debt-to-assets is 45.5%. Total assets: $5.4B.
Analyst outlook: 12 / 31 analysts rate XRAY as buy (39%) — mixed sentiment.
SharesGrow 7-Criteria breakdown: Value 60/100 (Pass), Growth 15/100 (Fail), Past 0/100 (Fail), Health 33/100 (Fail), Moat 65/100 (Partial), Future 40/100 (Partial), Income 10/100 (Fail).
